Revvity initiated with a Neutral at Guggenheim

Guggenheim last night initiated coverage of Revvity (RVTY) with a Neutral rating and no price target While the stock’s valuation screens attractively, Revvity is facing a host of company-specific challenges; while these are transitory and is unlikely to outperform peers in the near-term, the analyst tells investors in a research note. The firm believes Revvity’s organic revenue growth expectations for 2026 are likely too high due to China reimbursement challenges and difficult comparisons.